SourceOnes Cholesstrinol Formulas Lauded

CHICAGO—SourceOne Global Partners announced its Cholesstrinol™ family of heart-healthy formulas received the Heart Health Supplements Product Innovation of the Year Award from Frost & Sullivan, recognizing SourceOne for demonstrating outstanding achievement and superior performance in the heart health supplement marketplace. The annual award goes to a company that has best demonstrated the ability to develop and/or advance products with more innovative capabilities than competitors.

According to Frost and Sullivan, “The key factors in the success of Cholesstrinol have been strong science, understanding consumer concerns, strategic alliances, and an effective marketing campaign. SourceOne has followed a methodical approach in readying Cholesstrinol products and formulas for the marketplace. From establishing conclusive scientific evidence for its benefits to developing a specific and targeted media awareness campaign, SourceOne has displayed commendable understanding of the competitive factors in the nutritional ingredient marketplace.”

The Cholesstrinol family of ingredients and formulas includes TocoSource® Palm Tocotrienols and PMFsource® Citrus Flavonoids (as found in Sytrinol®), with specialty combinations of those ingredients plus OmegaChoice ™ Omega-3 Super-Concentrates, SterolSource® Phytosterols, OPC-Source® French Maritime Pine Bark and more.

Jesse Lopez, founder and president, SourceOne, said: “We are honored to receive this award in product innovation. Every product under the Cholesstrinol umbrella is supported by a strong platform of clinical evidence demonstrating conclusive ability to deliver a desirable range of heart-healthy benefits. These attributes may include significantly improving healthy total, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) and high-density lipoprotein (HDL) cholesterol and triglyceride levels, providing powerful antioxidant effects, promoting the body’s natural anti-inflammatory response and supporting healthy blood pressure levels. Cholesstrinol is a first in the industry as it represents a full turnkey solution for marketers to easily and cost-effectively address customized formulas for a wide range of consumers who want to support their heart health naturally.” Frost & Sullivan also commended SourceOne for its recent strategic partnership with Vesifact, Baar, Switzerland. Vesifact’s VESIsorb® delivery system, which was licensed exclusively worldwide to SourceOne, is a natural self-assembling colloid delivery system that has been clinically proven to increase absorption of medical, nutraceutical, and cosmetic ingredients. SourceOne uses the technology to improve delivery, bioavailability and efficacy of its science-based ingredients and proprietary formulas.